Vaccination numbers are rising and Canada is now emerging from the worst of the COVID-19 pandemic. This episode spotlights the Canadian Agency for Drugs and Technology in Health (CADTH) and how the organization is incorporating key lessons learned as it prepares to refresh its own strategy later this year.
CADTH’s previous strategic plan covered the period of 2018-2021, but due to the all-consuming obligations of COVID-19, the Agency decided to postpone the creation and launch of a new plan by 12 months. CADTH is now in the early days of formulating and crystallizing new strategic priorities that will come into effect April 1, 2022.
In this episode, Ross Wallace is joined by CADTH President & CEO Suzanne McGurn to discuss CADTH’s role during the pandemic, the Agency’s areas of future focus, global trends in health technology assessment – and their impact on Canada – and Suzanne’s own insights after 12 months at the helm of the organization.